Overview Benefits of GIK in Cardiac Surgery Patients Status: Active, not recruiting Trial end date: 2022-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the effects of modified glucose - insulin - potassium (GIK) therapy in cardiac surgery patients undergoing cardiopulmonary bypass (CPB). Phase: Phase 2 Details Lead Sponsor: Xijing HospitalTreatments: InsulinInsulin, Globin ZincPharmaceutical Solutions